Researchers have uncovered the role of an immune response, previously attributed only to inflammatory conditions, in asthma symptoms.
This immune response, “Th17”, is coordinated by a specific type of white blood cell that produced molecules that damage the lungs. This disrupts the lung’s control mechanisms that would prevent asthma in healthy individuals.
The new research could guide the creation of new medicines to block this immune response in people who experience severe asthma.
Read more at King's College London